How do you approach management of GLP-1 receptor agonist therapy in patients who develop NAION?
Community PollStarted
Do you discuss risk of NAION with patients on GLP-1 agonists?
46 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Ophthalmology · The George Washington University School of Medicine & Health Sciences
Answered on
Short answer is I recommend stopping the GLP-1 agonist if one eye has already developed NAION, for the sake of protecting the fellow eye.
The fact is, our knowledge is still growing in this matter. While some studies indicate links between GLP-1 agonists and NAION, there are so many discussions arou...
Join for free or sign in to see the full answer
Mednet Member
Ophthalmology · Ophthalmology Associates Of The Valley
Answered on
Great discussion. I think we are still far from a clear understanding of this topic. Much larger prospective studies are needed to provide more accurate guidance.
Join for free or sign in to see the full answer